The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-[(2-Trifluoromethyl-phenylamino)-methyl]-thiophene-2-carboxylic acid [4-(2-hydroxy-ethyl)-thiazol-2-yl]-amide ID: ALA4293631
PubChem CID: 145485790
Max Phase: Preclinical
Molecular Formula: C18H16F3N3O2S2
Molecular Weight: 427.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1nc(CCO)cs1)c1ccc(CNc2ccccc2C(F)(F)F)s1
Standard InChI: InChI=1S/C18H16F3N3O2S2/c19-18(20,21)13-3-1-2-4-14(13)22-9-12-5-6-15(28-12)16(26)24-17-23-11(7-8-25)10-27-17/h1-6,10,22,25H,7-9H2,(H,23,24,26)
Standard InChI Key: WLFKWVOZFNSZLL-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
36.0027 -16.3187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7175 -15.8999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4341 -16.3088 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.7134 -15.0750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.1464 -15.8927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8982 -16.2257 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.4471 -15.6098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0310 -14.8975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2250 -15.0733 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.2427 -15.9893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6921 -16.6084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1109 -17.3235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9201 -17.1460 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
34.7801 -18.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9602 -18.1705 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.6294 -18.9263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8102 -19.0130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4794 -19.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9687 -20.4331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7925 -20.3386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1195 -19.5835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3183 -18.3477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8751 -17.7418 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
32.5360 -17.5135 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
31.4574 -18.3027 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
40.2680 -15.6918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7495 -15.0219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5745 -15.0219 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 4 2 0
1 2 1 0
3 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
1 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 1 1 0
12 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
22 23 1 0
22 24 1 0
22 25 1 0
17 22 1 0
7 26 1 0
26 27 1 0
27 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 427.47Molecular Weight (Monoisotopic): 427.0636AlogP: 4.62#Rotatable Bonds: 7Polar Surface Area: 74.25Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.36CX Basic pKa: 1.62CX LogP: 4.08CX LogD: 4.08Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.51Np Likeness Score: -2.29
References 1. Iida T, Ubukata M, Mitani I, Nakagawa Y, Maeda K, Imai H, Ogoshi Y, Hotta T, Sakata S, Sano R, Morinaga H, Negoro T, Oshida S, Tanaka M, Inaba T.. (2018) Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity., 158 [PMID:30248655 ] [10.1016/j.ejmech.2018.09.003 ]